117 related articles for article (PubMed ID: 2123946)
1. [Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].
Moriuchi Y; Kamihira S; Yamamura M; Mori H; Miyazaki Y; Tokunaga S; Nonaka H; Amagasaki T; Yamada Y; Yoshida Y
Rinsho Ketsueki; 1990 Oct; 31(10):1664-9. PubMed ID: 2123946
[TBL] [Abstract][Full Text] [Related]
2. [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
López A; Soler JA; Juliá A; Novo A; Bueno J
Med Clin (Barc); 1994 Jan; 102(3):81-5. PubMed ID: 8133717
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin for infection prophylaxis in granulocytopenic patients with acute leukemia.
Cortellaro M; Cofrancesco E; Pasargiklian I; Bianchi R; Pozzoli E; Annaloro C; Ranzi ML; Mascheroni E; Polli N
Haematologica; 1990; 75(6):541-5. PubMed ID: 2098296
[TBL] [Abstract][Full Text] [Related]
4. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Pohlen M; Marx J; Mellmann A; Becker K; Mesters RM; Mikesch JH; Schliemann C; Lenz G; Müller-Tidow C; Büchner T; Krug U; Stelljes M; Karch H; Peters G; Gerth HU; Görlich D; Berdel WE
Haematologica; 2016 Oct; 101(10):1208-1215. PubMed ID: 27470601
[TBL] [Abstract][Full Text] [Related]
6. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
Carlson JW; Fowler JM; Saltzman AK; Carter JR; Chen MD; Mitchell SK; Dunn D; Carson LF; Adcock LL; Twiggs LB
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):415-20. PubMed ID: 7530677
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Przybylski DJ; Reeves DJ
Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
[TBL] [Abstract][Full Text] [Related]
9. Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora.
Jansen J; Cromer M; Akard L; Black JR; Wheat LJ; Allen SD
Am J Med; 1994 Apr; 96(4):335-41. PubMed ID: 8166152
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.
Ghadiany M; Rahimi H; Rezvani H; Mohammad Alizadeh A; Zamani N; Mehdizadeh M; Foratyazdi M
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e11-5. PubMed ID: 24330539
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study.
Hallböök H; Lidström AK; Pauksens K
Infect Dis (Lond); 2016; 48(6):443-8. PubMed ID: 27030917
[TBL] [Abstract][Full Text] [Related]
12. Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
Prentice HG; Hann IM; Nazareth B; Paterson P; Bhamra A; Kibbler CC
Br J Haematol; 2001 Oct; 115(1):46-52. PubMed ID: 11722408
[TBL] [Abstract][Full Text] [Related]
13. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
15. Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
Arning M; Wolf HH; Aul C; Heyll A; Scharf RE; Scheider W
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():137-42. PubMed ID: 2286588
[TBL] [Abstract][Full Text] [Related]
16. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Rahman A; Rizwan S; Waycaster C; Wall GM
Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
[TBL] [Abstract][Full Text] [Related]
17. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
Lee DG; Choi SM; Choi JH; Yoo JH; Park YH; Kim YJ; Lee S; Min CK; Kim HJ; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Korean J Intern Med; 2002 Mar; 17(1):38-44. PubMed ID: 12014211
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
Zinner SH
Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Yeh TC; Hou JY; Huang TH; Lu CH; Sun FJ; Huang HM; Liu HC
Sci Rep; 2021 Oct; 11(1):21142. PubMed ID: 34707164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]